Published in

Oxford University Press (OUP), Neuro-Oncology, 7(20), p. 975-985

DOI: 10.1093/neuonc/nox204

Links

Tools

Export citation

Search in Google Scholar

Quality of life in the GLARIUS trial randomizing bevacizumab/irinotecan versus temozolomide in newly diagnosed, MGMT-nonmethylated glioblastoma

Journal article published in 2017 by Niklas Schäfer, Martin Proescholdt, Joachim P. Steinbach, Astrid Weyerbrock, Peter Hau, Oliver Grauer, Roland Goldbrunner, Franziska Friedrich, Veit Rohde, Florian Ringel, Uwe Schlegel, Michael Sabel, Michael W. Ronellenfitsch, Martin Uhl, Stefan Grau and other authors.
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Upload
Green circle
Postprint: archiving allowed
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO